Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2022-06-30 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Closure of trading window
Regulatory Filings Classification · 95% confidence The document text is extremely short (113 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report content, or detailed information. Given the lack of content, this document cannot be classified as a full report or detailed filing. It is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2022-06-30 English
Pursuant to the above Regulations, we wish to inform that the Trading Window for dealing in securities of Wanbury Limited (the "Company") shall remain closed for the Designated Persons ....
Regulatory Filings
2022-06-30 English
Financial Result Updates
Annual Report Classification · 95% confidence The document is a detailed announcement from Wanbury Limited dated 22nd June 2022, addressed to stock exchanges (BSE and NSE). It reports the outcome of a Board Meeting where the Board approved the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31st March 2022. The document includes the audited financial results, the auditor's report with an unmodified opinion, and details about the allotment of shares under an employee stock option plan. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, including auditor's report and financial results, not just an announcement or a certification. It is not merely a report publication announcement or a certification letter. The content aligns with a comprehensive financial report for a full fiscal year, which fits the definition of an Annual Report (10-K equivalent). Therefore, the document should be classified as an Annual Report (10-K).
2022-06-22 English
Outcome of Board Meeting
Earnings Release Classification · 95% confidence The document is a detailed announcement from Wanbury Limited regarding the outcome of a Board Meeting held on 22nd June 2022. It includes the approval of Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31st March 2022. The document also encloses the Auditor's Report with an unmodified opinion on these results. Additionally, it discusses the allotment of equity shares under the Employee Stock Option Plan and provides annexures related to the share allotment and regulatory disclosures. The document is lengthy (15,000 characters) and contains substantive financial data and auditor's opinions, not merely an announcement or a certification. It is not a short notice or a simple declaration but a comprehensive disclosure of audited financial results and related information. Therefore, this document fits the classification of an Earnings Release (ER) as it announces quarterly and annual financial results with auditor's report and share allotment details, which is typical for earnings releases in Indian regulatory filings under SEBI regulations.
2022-06-22 English
This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, 22nd June, 2022 has ....
Regulatory Filings
2022-06-22 English
This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, 22nd June, 2022 has ....
Regulatory Filings
2022-06-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.